Melbourne's Peter MacCallum Cancer Centre to be home of 'the next great wave in treatment'

25 March 2019 - A new form of cancer treatment that uses cell therapy to attack the disease will become ...

Read more →

Chile takes several ‘unorthodox’ steps to push back on drug prices, angering pharma

18 March 2019 - Searching for ways to beat back rising drug costs, the Chilean legislature is advancing three measures ...

Read more →

Ohio accuses UnitedHealth's OptumRx of drug overcharges in lawsuit

18 March 2019 - Ohio’s attorney general on Monday said he had filed a lawsuit against UnitedHealth Group Inc’s OptumRx unit, ...

Read more →

Medicines only work if patients can afford them: solutions for the high drug prices era

18 March 2019 - Since 2000, more than 500 new medicines have been approved by the FDA.  ...

Read more →

U.S. FDA accepts BLA filing of Aimmune Therapeutics’ AR101 for peanut allergy

18 March 2019 - If approved, AR101 will be the first medicine for this life-threatening condition. ...

Read more →

Allergan announces FDA approval of Avycaz (ceftazidime and avibactam) for paediatric patients

18 March 2019 - Label now includes new data on use of Avycaz for treatment of cUTI and cIAI in paediatric ...

Read more →

The policy initiatives Scott Gottlieb championed at the FDA will remain after he departs

18 March 2019 - The resignation of Scott Gottlieb as commissioner of the Food and Drug Administration raises a big ...

Read more →

The impact of pharmaceutical rebates on patients’ drug expenditures

18 March 2019 - The drug-pricing landscape in Canada is complex, with 4 different agencies and each provincial, territorial and federal ...

Read more →

Three new drugs added to PBS to ease cost pain

19 March 2019 - Three new treatments to help save or prolong the lives of thousands of Australians suffering from ...

Read more →

New early breast cancer drug to reduce risk of recurrence or death approved for Australian women

18 March 2019 - Nerlynx (neratinib) now approved by the Therapeutic Goods Administration for Australian women. ...

Read more →

CytoDyn reaches historical milestone, submits first of three sections of BLA to FDA for leronlimab (PRO 140) as a combination therapy for HIV

18 March 2019 - FDA previously granted rolling review for BLA. ...

Read more →

Outside political groups not always what they appear

18 March 2019 - As ominous music plays in the background, the narrator of a radio ad echoes objections from ...

Read more →

CMA drops anti-competitive case against MSD

18 March 2019 - The Competition and Markets Authority has closed its investigation into a suspected anti-competitive discount scheme developed ...

Read more →

NICE celebrates its 20th anniversary

18 March 2019 - Organisation was founded in April 1999 to improve outcome for health service users ...

Read more →

Praluent (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease

15 March 2019 - Approval is based on ODYSSEY OUTCOMES trial of 18,924 patients who recently suffered an acute coronary syndrome ...

Read more →

Brexit - implications for therapeutic goods in Australia

18 March 2019 - In the event of a 'no deal' exit of the United Kingdom from the European Union, ...

Read more →